{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:36:07Z","timestamp":1792888567947,"version":"4.5.0"},"reference-count":324,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002713","name":"Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023673","name":"Imam Mohammed Ibn Saud Islamic University Deanship of Scientific Research","doi-asserted-by":"publisher","award":["IMSIU-DDRSP2601"],"award-info":[{"award-number":["IMSIU-DDRSP2601"]}],"id":[{"id":"10.13039\/501100023673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bcp.2026.118032","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T23:20:12Z","timestamp":1778196012000},"page":"118032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Cannabinoids in autoimmune diseases: mechanistic insights and translational challenges"],"prefix":"10.1016","volume":"250","author":[{"given":"Yasir Akhtar","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Anas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubashshir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al-Zharani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahd A.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajhul","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4155-9479","authenticated-orcid":false,"given":"Shakilur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-024-01952-8","article-title":"Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders","volume":"9","author":"Song","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118032_b0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lfs.2018.04.054","article-title":"Enhanced endocannabinoid tone as a potential target of pharmacotherapy","volume":"204","author":"Toczek","year":"2018","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b0015","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.3390\/ijms26125707","article-title":"Endocannabinoid tone and oxylipins in rheumatoid arthritis and osteoarthritis\u2014a novel target for the treatment of pain and inflammation?","volume":"26","author":"Klawitter","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2026.118032_b0020","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.3390\/ijms22115479","article-title":"Endocannabinoid system and its regulation by polyunsaturated fatty acids and full spectrum hemp oils","volume":"22","author":"Komarnytsky","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/imm.13378","article-title":"Endocannabinoids in immune regulation and immunopathologies","volume":"164","author":"Rahaman","year":"2021","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0030","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-pharmtox-052220-021800","article-title":"A endocannabinoid-based therapies","volume":"62","author":"Piomelli","year":"2022","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118032_b0035","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","article-title":"Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease","volume":"85","author":"Borrelli","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"14","key":"10.1016\/j.bcp.2026.118032_b0040","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.3390\/ijms26146570","article-title":"Anti-inflammatory effects of cannabinoids in therapy of neurodegenerative disorders and inflammatory diseases of the CNS","volume":"26","author":"Tomaszewska-Zaremba","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b0045","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.clinthera.2022.10.003","article-title":"A systematic review of medical cannabinoids dosing in human","volume":"44","author":"Campos","year":"2022","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bcp.2026.118032_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107657","article-title":"A Comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders","volume":"213","author":"Garc\u00eda-Guti\u00e9rrez","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0055","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/cells10030586","article-title":"The endocannabinoid system and PPARs: focus on their signalling crosstalk, action and transcriptional regulation","volume":"10","author":"Iannotti","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/imm.12441","article-title":"Endocannabinoid signalling in innate and adaptive immunity","volume":"144","author":"Chiurchi\u00f9","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2026.118032_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1528759","article-title":"The endocannabinoid anandamide prevents TH17 programming of activated T lymphocytes while preserving TH1 responses","volume":"15","author":"Kiprina","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b0070","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.3390\/ijms25126402","article-title":"Cannabinoids\u2019 role in modulating central and peripheral immunity in neurodegenerative diseases","volume":"25","author":"Sharon","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b0075","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.3390\/cells10123396","article-title":"Endocannabinoid system and tumour microenvironment: new intertwined connections for anticancer approaches","volume":"10","author":"Iozzo","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118032_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/or.2025.1573797","article-title":"The endocannabinoid system in cancer biology: a mini-review of mechanisms and therapeutic potential","volume":"19","author":"Salum","year":"2025","journal-title":"Oncol. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b0085","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3390\/ijms27020757","article-title":"Cannabidiol as a prophylactic agent against glioblastoma growth: a preclinical investigation","volume":"27","author":"Wang","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118032_b0090","first-page":"19","article-title":"Therapeutic potential of cannabinoids: from health to disease","author":"Lopes Salles","year":"2025","journal-title":"Front. Neurosci."},{"issue":"24","key":"10.1016\/j.bcp.2026.118032_b0095","doi-asserted-by":"crossref","first-page":"13539","DOI":"10.3390\/ijms252413539","article-title":"Cannabichromene as a novel inhibitor of Th2 cytokine and JAK\/STAT pathway activation in atopic dermatitis models","volume":"25","author":"Kim","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0100","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41385-021-00455-x","article-title":"Cannabinoids induce functional tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming","volume":"15","author":"Angelina","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.bcp.2026.118032_b0105","first-page":"11","article-title":"Cannabinoids as key regulators of inflammasome signaling: a current perspective","author":"Suryavanshi","year":"2021","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.bcp.2026.118032_b0110","doi-asserted-by":"crossref","first-page":"11132","DOI":"10.3390\/ijms262211132","article-title":"The endocannabinoid system in human disease: molecular signaling, receptor pharmacology, and therapeutic innovation","volume":"26","author":"\u0218erban","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118032_b0115","first-page":"16","article-title":"Reframing type 1 diabetes through the endocannabinoidome-microbiota axis: a systems biology perspective","author":"\u0141ukowski","year":"2025","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"23","key":"10.1016\/j.bcp.2026.118032_b0120","doi-asserted-by":"crossref","first-page":"8929","DOI":"10.3390\/ijms21238929","article-title":"The immune endocannabinoid system of the tumor microenvironment","volume":"21","author":"Kienzl","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.118032_b0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11481-021-10023-6","article-title":"Effects of orally administered cannabidiol on neuroinflammation and intestinal inflammation in the attenuation of experimental autoimmune encephalomyelitis","volume":"17","author":"Dopkins","year":"2022","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bcp.2026.118032_b1035","first-page":"10","article-title":"Combination of cannabinoids, \u03949- tetrahydrocannabinol and cannabidiol, ameliorates experimental multiple sclerosis by suppressing neuroinflammation through regulation of MiRNA-mediated signaling pathways","author":"Al-Ghezi","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118032_b1390","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1476-5381.2011.01379.x","article-title":"Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis\u2010like disease in C57BL\/6 mice","volume":"163","author":"Kozela","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118032_b1395","first-page":"9","article-title":"Cannabidiol attenuates experimental autoimmune encephalomyelitis model of multiple sclerosis through induction of myeloid-derived suppressor cells","author":"Elliott","year":"2018","journal-title":"Front. Immunol."},{"issue":"6773","key":"10.1016\/j.bcp.2026.118032_b1400","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35003583","article-title":"Cannabinoids control spasticity and tremor in a multiple sclerosis model","volume":"404","author":"Baker","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118032_b1405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2015.04.002","article-title":"Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","volume":"595","author":"Fu","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b1410","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/biom13020376","article-title":"Therapeutic potential of phytocannabinoid cannabigerol for multiple sclerosis: modulation of microglial activation in vitro and in vivo","volume":"13","author":"Fleisher-Berkovich","year":"2023","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b1415","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.bjp.0707003","article-title":"Control of spasticity in a multiple sclerosis model is mediated by CB 1, not CB2 cannabinoid receptors","volume":"150","author":"Pryce","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.bcp.2026.118032_b1420","doi-asserted-by":"crossref","first-page":"9561","DOI":"10.1073\/pnas.160105897","article-title":"The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis","volume":"97","author":"Malfait","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b1425","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/jbmr.3637","article-title":"Cannabinoid receptor 2 agonist prevents local and systemic inflammatory bone destruction in rheumatoid arthritis","volume":"34","author":"Zhu","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.bcp.2026.118032_b1430","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/biom9080326","article-title":"\u03b2-caryophyllene mitigates collagen antibody induced arthritis (CAIA) in mice through a cross-talk between CB2 and PPAR-\u03b3 receptors","volume":"9","author":"Irrera","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2026.118032_b0450","first-page":"16","article-title":"Cannabinoid receptor 2 selective agonist ameliorates adjuvant-induced arthritis by modulating the balance between treg and Th17 cells","author":"Tian","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118032_b0435","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1705962","article-title":"Regulation of inflammatory pathways by cannabigerol in the collagen induced arthritis model in rats","volume":"16","author":"\u0160teigerov\u00e1","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"6S","key":"10.1016\/j.bcp.2026.118032_b1435","doi-asserted-by":"crossref","first-page":"S408","DOI":"10.1097\/SAP.0000000000003547","article-title":"The mechanism of cannabichromene and cannabidiol alone versus in combination in the alleviation of arthritis-related inflammation","volume":"90","author":"Grogan","year":"2023","journal-title":"Ann. Plast. Surg."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0525","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/can.2020.0177","article-title":"Monoacylglycerol lipase inhibition using JZL184 attenuates paw inflammation and functional deficits in a mouse model of inflammatory arthritis","volume":"6","author":"Nass","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"issue":"23","key":"10.1016\/j.bcp.2026.118032_b0460","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3390\/cells13232013","article-title":"Comprehensive assessment of cannabidiol and HU308 in acute and chronic colitis models: efficacy, safety, and mechanistic innovations","volume":"13","author":"Thapa","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118032_b1440","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00341","article-title":"An orally active cannabis extract with high content in cannabidiol attenuates chemically-induced intestinal inflammation and hypermotility in the mouse","volume":"7","author":"Pagano","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b1445","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/ecco-jcc\/jjaa253","article-title":"Cannabinoid receptor activation on haematopoietic cells and enterocytes protects against colitis","volume":"15","author":"Becker","year":"2021","journal-title":"J. Crohns Colitis"},{"issue":"10","key":"10.1016\/j.bcp.2026.118032_b0745","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/nmo.12639","article-title":"The GPR 55 Antagonist CID 16020046 protects against intestinal inflammation","volume":"27","author":"Stan\u010di\u0107","year":"2015","journal-title":"Neurogastroenterol. Motility"},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b0470","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.taap.2011.11.005","article-title":"Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10\u2212\/\u2212 mice by attenuating the activation of T cells and promoting their apoptosis","volume":"258","author":"Singh","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118032_b0515","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbi.2016.06.008","article-title":"Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering MicroRNA expression and suppressing inflammation","volume":"59","author":"Shamran","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bcp.2026.118032_b1450","first-page":"2190","article-title":"Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of P38 MAPK activation","volume":"14","author":"El-Remessy","year":"2008","journal-title":"Mol. Vis."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b1455","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1189\/jlb.0307159","article-title":"Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis","volume":"82","author":"Xu","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1460","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2007.06.029","article-title":"Cannabidiol arrests onset of autoimmune diabetes in NOD mice","volume":"54","author":"Weiss","year":"2008","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b1465","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/08916930500356674","article-title":"Cannabidiol lowers incidence of diabetes in non-obese diabetic mice","volume":"39","author":"Weiss","year":"2006","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b1470","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11357-022-00565-9","article-title":"Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis","volume":"44","author":"Rajesh","year":"2022","journal-title":"Geroscience"},{"issue":"Supplement_1","key":"10.1016\/j.bcp.2026.118032_b1475","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.184.Supp.140.4","article-title":"Cannabidiol attenuates experimental autoimmune hepatitis by inducing accumulation of myeloid-derived suppressor cells (MDSCs) in liver (140.4)","volume":"184","author":"Hegde","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0780","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/mol.108.047035","article-title":"Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells","volume":"74","author":"Hegde","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b1480","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jdermsci.2006.10.009","article-title":"Cannabinoids inhibit human keratinocyte proliferation through a non-CB1\/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis","volume":"45","author":"Wilkinson","year":"2007","journal-title":"J. Dermatol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2026.118032_b1485","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3390\/cells8080827","article-title":"Cannabidiol regulates the expression of keratinocyte proteins involved in the inflammation process through transcriptional regulation","volume":"8","author":"Jastrz\u0105b","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118032_b1490","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101321","article-title":"Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1","volume":"28","author":"Casares","year":"2020","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b1495","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s10753-023-01805-6","article-title":"Specific activation of CB2R ameliorates psoriasis-like skin lesions by inhibiting inflammation and oxidative stress","volume":"46","author":"He","year":"2023","journal-title":"Inflammation"},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b1500","first-page":"741","article-title":"Cannabidiol Treatment in a murine model of systemic lupus erythematosus accelerates proteinuria development","volume":"20","author":"Katz-Talmor","year":"2018","journal-title":"Isr. Med. Assoc. J."},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b1505","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1111\/exd.14935","article-title":"Nano\u2010encapsulated anandamide reduces inflammatory cytokines in vitro and lesion severity in a murine model of cutaneous lupus erythematosus","volume":"32","author":"McCormick","year":"2023","journal-title":"Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11481-021-09982-7","article-title":"Immunomodulatory potential of cannabidiol in multiple sclerosis: a systematic review","volume":"16","author":"Furgiuele","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/ars.2017.7144","article-title":"Neuroprotection in oxidative stress-related neurodegenerative diseases: role of endocannabinoid system modulation","volume":"29","author":"Paloczi","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2026.118032_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1045030","article-title":"Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPAR\u03b1) in the synovial membrane of the horse metacarpophalangeal joint","volume":"10","author":"Zamith Cunha","year":"2023","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.bcp.2026.118032_b0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/bs.apha.2021.10.006","article-title":"Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond","volume":"93","author":"Hempel","year":"2022","journal-title":"Adv. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0145","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.bcp.2026.118032_b0150","doi-asserted-by":"crossref","first-page":"16728","DOI":"10.3390\/ijms242316728","article-title":"Neuroprotection and beyond: the central role of CB1 and CB2 receptors in stroke recovery","volume":"24","author":"Bietar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0155","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12035-026-05780-5","article-title":"Neuroprotective role of cannabinoid CB1 and GPR55 receptors in a cell model of multiple sclerosis","volume":"63","author":"Mart\u00ednez-Pinilla","year":"2026","journal-title":"Mol. Neurobiol."},{"issue":"17","key":"10.1016\/j.bcp.2026.118032_b0160","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.3390\/molecules26175413","article-title":"CB1 cannabinoid receptor signaling and biased signaling","volume":"26","author":"Leo","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0165","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/biof.1936","article-title":"Cannabinoids in neuroinflammatory disorders: focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases","volume":"49","author":"Abd-Nikfarjam","year":"2023","journal-title":"Biofactors"},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b0170","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3390\/pharmaceutics15041151","article-title":"Cannabinoids and multiple sclerosis: a critical analysis of therapeutic potentials and safety concerns","volume":"15","author":"Nouh","year":"2023","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.bcp.2026.118032_b0175","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3390\/antiox11102049","article-title":"Intracellular molecular targets and signaling pathways involved in antioxidative and neuroprotective effects of cannabinoids in neurodegenerative conditions","volume":"11","author":"Tadijan","year":"2022","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s44446-025-00005-7","article-title":"Cannabidiol as an immune modulator: a comprehensive review","volume":"33","author":"Mujahid","year":"2025","journal-title":"Saudi Pharma. J."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0185","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1038\/s41598-025-33360-5","article-title":"Cannabidiol perturbs macrophage polarization by interfering with the metabolic flux and PI3K\/Akt pathway","volume":"16","author":"Sukdee","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b0190","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaip.2022.10.009","article-title":"Immunomodulatory actions of cannabinoids: clinical correlates and therapeutic opportunities for allergic inflammation","volume":"11","author":"Nayak","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0200","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.3390\/ijms24032513","article-title":"Cannabinoids in the modulation of oxidative signaling","volume":"24","author":"Pagano","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2026.118032_b0205","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70099","article-title":"CB1 Receptor activation provides neuroprotection in an animal model of glutamate\u2010induced excitotoxicity through a reduction of NOX \u20102 activity and oxidative stress","volume":"30","author":"Mart\u00ednez-Torres","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s42238-025-00332-5","article-title":"The effects of cannabidiol on nitric oxide synthases: a narrative review on therapeutic implications for inflammation and oxidative stress in health and disease","volume":"7","author":"Hooshmand","year":"2025","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.bcp.2026.118032_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578180","article-title":"Microglia mediated neuroinflammation in neurodegenerative diseases: a review on the cell signaling pathways involved in microglial activation","volume":"383","author":"Biswas","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bcp.2026.118032_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1053680","article-title":"Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer\u2019s disease: a systematic review and meta-analysis of animal studies","volume":"14","author":"Kamaruzzaman","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b0225","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nm1561","article-title":"Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells","volume":"13","author":"Maresz","year":"2007","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b0230","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1089\/can.2020.0046","article-title":"The CB 1 receptor differentially regulates IFN-\u03b3 production in vitro and in experimental autoimmune encephalomyelitis","volume":"6","author":"Nichols","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"issue":"20","key":"10.1016\/j.bcp.2026.118032_b0235","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"23","key":"10.1016\/j.bcp.2026.118032_b0240","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.3390\/ijms20235874","article-title":"Allosteric modulation of cannabinoid receptor 1\u2014current challenges and future opportunities","volume":"20","author":"Hryhorowicz","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.bcp.2026.118032_b0245","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.3390\/ijms21228870","article-title":"Cannabidiol for pain treatment: focus on pharmacology and mechanism of action","volume":"21","author":"Mlost","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0250","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/ijms26010152","article-title":"Cannabinoids: role in neurological diseases and psychiatric disorders","volume":"26","author":"Kumar","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118032_b0255","first-page":"13","article-title":"Medicinal cannabis and central nervous system disorders","author":"Ortiz","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b0260","first-page":"607","article-title":"Review of the endocannabinoid system","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/receptors1010002","article-title":"Pharmacology of minor cannabinoids at the cannabinoid CB1 receptor: isomer- and ligand-dependent antagonism by tetrahydrocannabivarin","volume":"1","author":"Walsh","year":"2022","journal-title":"Receptors"},{"issue":"9","key":"10.1016\/j.bcp.2026.118032_b0270","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/biom15091329","article-title":"Tetrahydrocannabivarin (THCV) dose dependently blocks or substitutes for tetrahydrocannabinol (THC) in a drug discrimination task in rats","volume":"15","author":"Kayir","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2026.118032_b0275","first-page":"13","article-title":"Role of G protein-coupled receptors in microglial activation: implication in Parkinson\u2019s disease","author":"Gu","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0280","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41467-024-55808-4","article-title":"Structural basis of THC analog activity at the cannabinoid 1 receptor","volume":"16","author":"Thorsen","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40001-023-01443-6","article-title":"The synthetic cannabinoids menace: a review of health risks and toxicity","volume":"29","author":"Alzu\u2019bi","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0290","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3390\/ddc2030035","article-title":"Requiem for rimonabant: therapeutic potential for cannabinoid CB1 receptor antagonists after the fall","volume":"2","author":"Bosquez-Berger","year":"2023","journal-title":"Drugs and Drug Candidates"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0295","doi-asserted-by":"crossref","first-page":"10694","DOI":"10.1038\/s41467-024-54206-0","article-title":"Structural mechanism of CB1R binding to peripheral and biased inverse agonists","volume":"15","author":"Kumari","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bcp.2026.118032_b0300","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.cell.2022.04.005","article-title":"Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation","volume":"185","author":"Wei","year":"2022","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.118032_b0305","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2010.12.005","article-title":"Inverse agonism of cannabinoid CB1 receptor blocks the adhesion of encephalitogenic T cells in inflamed brain venules by a protein kinase a-dependent mechanism","volume":"233","author":"Rossi","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41420-022-01064-8","article-title":"Cannabinoid receptor-1 suppresses M2 macrophage polarization in colorectal cancer by downregulating EGFR","volume":"8","author":"Deng","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bcp.2026.118032_b0315","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1296906","article-title":"Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?","volume":"13","author":"Sarsembayeva","year":"2023","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b0320","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3390\/cells10061282","article-title":"The interplay between the immune and the endocannabinoid systems in cancer","volume":"10","author":"Braile","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0325","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12916-022-02459-1","article-title":"Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications","volume":"20","author":"Bilbao","year":"2022","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0330","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clinthera.2024.09.004","article-title":"Medical cannabis dosing trajectories of patients: evidence from sales data","volume":"48","author":"Kritikos","year":"2026","journal-title":"Clin. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b0335","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1021\/jm201731z","article-title":"Design and synthesis of cannabinoid receptor 1 antagonists for peripheral selectivity","volume":"55","author":"Fulp","year":"2012","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2026.118032_b0340","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2174\/1568026619666190708164841","article-title":"Overcoming the psychiatric side effects of the cannabinoid CB1 receptor antagonists: current approaches for therapeutics development","volume":"19","author":"Nguyen","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"issue":"20","key":"10.1016\/j.bcp.2026.118032_b0345","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.3390\/molecules26206178","article-title":"The peripheral cannabinoid receptor type 1 (CB1) as a molecular target for modulating body weight in man","volume":"26","author":"O\u2019Sullivan","year":"2021","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b0350","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/dna5040059","article-title":"The CB2 receptor in immune regulation and disease: genetic architecture, epigenetic control, and emerging therapeutic strategies","volume":"5","author":"Kalkan","year":"2025","journal-title":"DNA"},{"issue":"14","key":"10.1016\/j.bcp.2026.118032_b0355","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.3390\/molecules29143381","article-title":"The impact of the CB2 cannabinoid receptor in inflammatory diseases: an update","volume":"29","author":"Rakotoarivelo","year":"2024","journal-title":"Molecules"},{"issue":"17","key":"10.1016\/j.bcp.2026.118032_b0360","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.3390\/ijms26178657","article-title":"Cannabinoid receptor 2 (CB2) in macrophages: a promising clinical target for immune disorders","volume":"26","author":"Yoon","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0365","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.3390\/ijms24032348","article-title":"Microglial cannabinoid CB2 receptors in pain modulation","volume":"24","author":"Xu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0370","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-024-03202-8","article-title":"CB2 expression in mouse brain: from mapping to regulation in microglia under inflammatory conditions","volume":"21","author":"Grabon","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"21","key":"10.1016\/j.bcp.2026.118032_b0375","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1111\/bph.70116","article-title":"Cannabinoid CB 2 receptor\u2010mediated analgesia: mechanism\u2010based insights and therapeutic potential","volume":"182","author":"Guenther","year":"2025","journal-title":"Br. J. Pharmacol."},{"issue":"23","key":"10.1016\/j.bcp.2026.118032_b0380","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b0385","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1089\/can.2024.0063","article-title":"Endocannabinoid receptor 2 function is associated with tumor-associated macrophage accumulation and increases in T cell number to initiate a potent antitumor response in a syngeneic murine model of glioblastoma","volume":"9","author":"Duan","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.bcp.2026.118032_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154771","article-title":"Cannabidiol goes nuclear: the role of PPAR\u03b3","volume":"114","author":"Khosropoor","year":"2023","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0395","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s10020-021-00351-x","article-title":"CB2-mediated attenuation of nucleus pulposus degeneration via the amelioration of inflammation and oxidative stress in vivo and in vitro","volume":"27","author":"Cheng","year":"2021","journal-title":"Mol. Med."},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b0400","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/cns.12349","article-title":"Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP 3 inflammasome","volume":"20","author":"Shao","year":"2014","journal-title":"CNS Neurosci. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b0405","doi-asserted-by":"crossref","first-page":"H2210","DOI":"10.1152\/ajpheart.00688.2007","article-title":"CB 2 -receptor stimulation attenuates TNF-\u03b1-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion","volume":"293","author":"Rajesh","year":"2007","journal-title":"Am. J. Physiol.-Heart Circulat. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0410","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1186\/s40001-024-02207-6","article-title":"Involvement of CXCL12\/CXCR4 in CB2 receptor agonist-attenuated morphine tolerance in walker 256 tumor-bearing rats with cancer pain","volume":"29","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.bcp.2026.118032_b0415","first-page":"11","article-title":"Cannabinoid ligands targeting TRP channels","author":"Muller","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"8","key":"10.1016\/j.bcp.2026.118032_b0420","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.3390\/ijms25084204","article-title":"Phytocannabinoids: exploring pharmacological profiles and their impact on therapeutical use","volume":"25","author":"Blebea","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b0425","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/cells14020083","article-title":"Anti-inflammatory effects of cannabigerol in vitro and in vivo are mediated through the JAK\/STAT\/NF\u03baB signaling pathway","volume":"14","author":"Jeong","year":"2025","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0430","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/jpet.124.002204","article-title":"High cannabigerol hemp extract moderates colitis and modulates the microbiome in an inflammatory bowel disease model","volume":"390","author":"Anderson","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2026.118032_b0440","article-title":"Activation of CB2 receptors by (\u2212)-cannabichromene but not (+)-cannabichromene","author":"Udoh","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2013.11.002","article-title":"Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS","volume":"287","author":"Kong","year":"2014","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0455","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s10020-024-01012-5","article-title":"AM1241 inhibits chondrocyte inflammation and ECM degradation through the Nrf2\/HO-1 and NF-\u039aB pathways and alleviates osteoarthritis in mice","volume":"31","author":"Zou","year":"2025","journal-title":"Mol. Med."},{"issue":"11","key":"10.1016\/j.bcp.2026.118032_b0465","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/ibd.20960","article-title":"Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis","volume":"15","author":"Storr","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bcp.2026.118032_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103233","article-title":"Cannabinoid receptor 2 selective agonist alleviates systemic sclerosis by inhibiting Th2 differentiation through JAK\/SOCS3 signaling","volume":"147","author":"Tian","year":"2024","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0480","article-title":"Safety, pharmacokinetics, and efficacy of olorinab, a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, in a phase 2a study of patients with chronic abdominal pain associated with crohn\u2019s disease","volume":"3","author":"Yacyshyn","year":"2021","journal-title":"Crohns Colitis 360"},{"issue":"7","key":"10.1016\/j.bcp.2026.118032_b1510","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101301","article-title":"Cannabinoids and cannabinoid receptors: the story so far","volume":"23","author":"Shahbazi","year":"2020","journal-title":"Iscience"},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b1515","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/acschemneuro.4c00343","article-title":"Determination of the negative allosteric binding site of cannabidiol at the CB1 receptor: a combined computational and site-directed mutagenesis study","volume":"16","author":"Pandey","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bcp.2026.118032_b0650","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00632","article-title":"Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1\u2013CB2 heteroreceptor complexes","volume":"9","author":"Navarro","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1520","doi-asserted-by":"crossref","first-page":"20405","DOI":"10.1038\/s41598-020-77175-y","article-title":"In vitro and in vivo pharmacological activity of minor cannabinoids isolated from cannabis sativa","volume":"10","author":"Zagzoog","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b1525","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/cells13060480","article-title":"Functional selectivity of cannabinoid type 1 G protein-coupled receptor agonists in transactivating glycosylated receptors on cancer cells to induce epithelial\u2013mesenchymal transition metastatic phenotype","volume":"13","author":"Bunsick","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118032_b1530","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2026.178735","article-title":"Functional selectivity of cannabinoids at CB1 receptors: comprehensive analysis of G proteins, \u03b2-arrestin and CAMP signalling dynamics in HEK293T cells","volume":"1019","author":"AlAli","year":"2026","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0485","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12974-023-02701-4","article-title":"Inhibition of 2-arachidonoylglycerol degradation enhances glial immunity by single-cell transcriptomic analysis","volume":"20","author":"Zhu","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2026.118032_b0490","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.2147\/DDDT.S462785","article-title":"Endocannabinoid hydrolase inhibitors: potential novel anxiolytic drugs","volume":"18","author":"Zhao","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b0495","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.3390\/molecules23123167","article-title":"Characterization of endocannabinoid-metabolizing enzymes in human peripheral blood mononuclear cells under inflammatory conditions","volume":"23","author":"Szafran","year":"2018","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bcp.2026.118032_b0500","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/cbdv.200790155","article-title":"Biosynthetic pathways of the endocannabinoid anandamide","volume":"4","author":"Okamoto","year":"2007","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0505","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41598-019-38865-4","article-title":"Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer","volume":"9","author":"Grill","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2026.118032_b0510","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/mi.2011.18","article-title":"The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease","volume":"4","author":"Di Sabatino","year":"2011","journal-title":"Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b0520","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.pbb.2011.06.022","article-title":"Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice","volume":"99","author":"Kinsey","year":"2011","journal-title":"Pharmacol. Biochem. Behav"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0530","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-pharmtox-030220-112741","article-title":"Targeting endocannabinoid signaling: FAAH and MAG lipase inhibitors","volume":"61","author":"van Egmond","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0535","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5152\/eurjrheum.2017.17025","article-title":"The endocannabinoid system in pain and inflammation: its relevance to rheumatic disease","volume":"4","author":"Barrie","year":"2019","journal-title":"Eur. J. Rheumatol."},{"key":"10.1016\/j.bcp.2026.118032_b0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108394","article-title":"Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases","volume":"244","author":"Chen","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0545","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/s41467-022-29124-8","article-title":"Opposite physiological and pathological MTORC1-mediated roles of the CB1 receptor in regulating renal tubular function","volume":"13","author":"Hinden","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b0550","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","article-title":"Is lipid signaling through cannabinoid 2 receptors part of a protective system?","volume":"50","author":"Pacher","year":"2011","journal-title":"Prog. Lipid Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0555","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1124\/jpet.111.182717","article-title":"Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model","volume":"338","author":"Pandey","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2026.118032_b0560","doi-asserted-by":"crossref","unstructured":"M. Chen, M. Shin, T.B. Ware, G. Donvito, K.H. Muchhala, R. Mischel, M.A. Mustafa, V. Serbulea, C.M. Upchurch, N. Leitinger, et al. Endocannabinoid biosynthetic enzymes regulate pain response via LKB1\u2013AMPK signaling. Proceedings of the National Academy of Sciences, 2023, 120 (52). doi:10.1073\/pnas.2304900120.","DOI":"10.1073\/pnas.2304900120"},{"issue":"14","key":"10.1016\/j.bcp.2026.118032_b0565","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/cmdc.202100120","article-title":"Anticancer potential of small\u2010molecule inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase","volume":"16","author":"Jaiswal","year":"2021","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0570","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2009.11.027","article-title":"Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis","volume":"140","author":"Nomura","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118032_b0575","first-page":"15","article-title":"GPR55 in the tumor microenvironment of pancreatic cancer controls tumorigenesis","author":"Risti\u0107","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118032_b0580","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1184794","article-title":"The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy","volume":"14","author":"Sun","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118032_b0585","doi-asserted-by":"crossref","first-page":"9098","DOI":"10.3390\/ijms24109098","article-title":"\u201cThermoTRP\u201d channel expression in cancers: implications for diagnosis and prognosis (practical approach by a pathologist)","volume":"24","author":"Szallasi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118032_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176679","article-title":"A systematic review of novel cannabinoids and their targets: insights into the significance of structure in activity","volume":"976","author":"Abdollahzadeh Hamzekalayi","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118032_b0595","doi-asserted-by":"crossref","DOI":"10.3389\/fninf.2024.1294939","article-title":"In silico analyses of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution","volume":"18","author":"Cherry","year":"2024","journal-title":"Front. Neuroinform."},{"issue":"16","key":"10.1016\/j.bcp.2026.118032_b0600","doi-asserted-by":"crossref","first-page":"12760","DOI":"10.3390\/ijms241612760","article-title":"Molecular advances on cannabinoid and endocannabinoid research","volume":"24","author":"Meccariello","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b0605","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41401-024-01472-9","article-title":"Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery","volume":"46","author":"Shen","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0610","doi-asserted-by":"crossref","first-page":"F476","DOI":"10.1152\/ajprenal.00125.2024","article-title":"TRPV1 and mast cell involvement in repeated variate stress-induced urinary bladder dysfunction in adult female mice","volume":"327","author":"Sidwell","year":"2024","journal-title":"Am. J. Physiol.-Renal Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b0615","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s10753-024-02024-3","article-title":"TRPV1 regulates proinflammatory properties of M1 macrophages in periodontitis Via NRF2","volume":"47","author":"Li","year":"2024","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b0620","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jointm.2024.01.008","article-title":"TRPV1: the key bridge in neuroimmune interactions","volume":"4","author":"Chen","year":"2024","journal-title":"J. Intens. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0625","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13569","article-title":"Transient receptor potential vanilloid 1: a potential therapeutic target for the treatment of osteoarthritis and rheumatoid arthritis","volume":"57","author":"Liao","year":"2024","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bcp.2026.118032_b0630","article-title":"Function of TRP channels in monocytes\/macrophages","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118032_b0635","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s13238-017-0395-5","article-title":"TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization","volume":"8","author":"Gouin","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.bcp.2026.118032_b0640","article-title":"TRPV1 suppresses microglial inflammatory activation to ameliorate schizophrenia-associated behaviors in maternal separation rats","author":"Chen","year":"2025","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b0645","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/bab.2119","article-title":"CBD activation of TRPV1 induces oxidative signaling and subsequent ER stress in breast cancer cell lines","volume":"69","author":"de la Harpe","year":"2022","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"11","key":"10.1016\/j.bcp.2026.118032_b0655","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/cn5000524","article-title":"Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability","volume":"5","author":"Iannotti","year":"2014","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0660","doi-asserted-by":"crossref","DOI":"10.1080\/19336950.2026.2616902","article-title":"TRPV1 from the TRP family: structure, function, implication in autoimmune diseases and potential therapies","volume":"20","author":"Bejoma","year":"2026","journal-title":"Channels"},{"issue":"9","key":"10.1016\/j.bcp.2026.118032_b0665","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.3390\/ijms23094529","article-title":"TRPA1 role in inflammatory disorders: what is known so far?","volume":"23","author":"Landini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118032_b0670","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1093925","article-title":"Inflammation\u2014the role of TRPA1 channel","volume":"14","author":"Yao","year":"2023","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2026.118032_b0675","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1017\/erm.2023.23","article-title":"Roles of TRP and PIEZO receptors in autoimmune diseases","volume":"26","author":"Yang","year":"2024","journal-title":"Expert Rev. Mol. Med."},{"issue":"10","key":"10.1016\/j.bcp.2026.118032_b0680","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3390\/biom13101557","article-title":"TRP channels in cancer: signaling mechanisms and translational approaches","volume":"13","author":"Marini","year":"2023","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b0685","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O\u2019Sullivan","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b0690","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1089\/ars.2018.7695","article-title":"Redox biology of peroxisome proliferator-activated receptor-\u03b3 in pulmonary hypertension","volume":"31","author":"Tseng","year":"2019","journal-title":"Antioxid. Redox Signal."},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b0695","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1742-4658.2010.07581.x","article-title":"Heme oxygenase\u20101\/P21 WAF1 mediates peroxisome proliferator\u2010activated receptor\u2010\u03b3 signaling inhibition of proliferation of rat pulmonary artery smooth muscle cells","volume":"277","author":"Li","year":"2010","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0700","doi-asserted-by":"crossref","DOI":"10.1042\/NS20200080","article-title":"Cannabidiol modulation of oxidative stress and signalling","volume":"5","author":"Pereira","year":"2021","journal-title":"Neuronal. Signal"},{"key":"10.1016\/j.bcp.2026.118032_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102489","article-title":"The molecular activity of cannabidiol in the regulation of Nrf2 system interacting with NF-\u039aB pathway under oxidative stress","volume":"57","author":"Atalay Ekiner","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2026.118032_b0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114517","article-title":"Cannabidiol regulates the activation of hepatic stellate cells by modulating the NOX4 and NF-\u039aB pathways","volume":"186","author":"Xie","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bcp.2026.118032_b0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105769","article-title":"Cannabidiol prevents LPS-induced inflammation by inhibiting the NLRP3 inflammasome and INOS activity in BV2 microglia cells via CB2 receptors and PPAR\u03b3","volume":"177","author":"da Rodrigues","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bcp.2026.118032_b0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102510","article-title":"The roles of PPAR\u03b3 and its agonists in autoimmune diseases: a comprehensive review","volume":"113","author":"Liu","year":"2020","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.bcp.2026.118032_b0725","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2026.118032_b0730","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/bph.14958","article-title":"Different receptor mechanisms underlying phytocannabinoid\u2010 versus synthetic cannabinoid\u2010induced tetrad effects: opposite roles of CB 1 \/CB 2 versus GPR55 receptors","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118032_b0735","first-page":"103","article-title":"Molecular targets of the phytocannabinoids","author":"Morales","year":"2017","journal-title":"A Complex Picture"},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b0740","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"de Almeida","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"issue":"5","key":"10.1016\/j.bcp.2026.118032_b0750","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3892\/mmr.2022.12671","article-title":"CID16020046, a GPR55 antagonist, attenuates sepsis\u2013induced acute kidney injury","volume":"25","author":"Chen","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0755","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12974-018-1362-7","article-title":"Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells","volume":"15","author":"Saliba","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b0760","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3390\/molecules29061258","article-title":"Uncovering the power of GPR18 signalling: how RvD2 and other ligands could have the potential to modulate and resolve inflammation in various health disorders","volume":"29","author":"Honkisz-Orzechowska","year":"2024","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.bcp.2026.118032_b0765","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1021\/acs.jmedchem.0c00926","article-title":"Therapeutic exploitation of GPR18: beyond the cannabinoids?","volume":"63","author":"Morales","year":"2020","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2026.118032_b0770","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1476-5381.2011.01327.x","article-title":"The endocannabinoid system and cancer: therapeutic implication","volume":"163","author":"Guindon","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118032_b0775","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4155\/fmc.09.93","article-title":"Cannabinoids as novel anti-inflammatory drugs","volume":"1","author":"Nagarkatti","year":"2009","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0785","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/can.2018.0073","article-title":"Immune responses regulated by cannabidiol","volume":"5","author":"Nichols","year":"2020","journal-title":"Cannabis Cannabinoid Res."},{"issue":"27","key":"10.1016\/j.bcp.2026.118032_b0790","doi-asserted-by":"crossref","first-page":"18707","DOI":"10.1074\/jbc.M113.545210","article-title":"Histone modifications are associated with \u03949-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses","volume":"289","author":"Yang","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2026.118032_b0795","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0800","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12974-015-0273-0","article-title":"Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells","volume":"12","author":"Kozela","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.bcp.2026.118032_b0805","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.imbio.2009.04.001","article-title":"Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression","volume":"215","author":"Rieder","year":"2010","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0810","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41423-020-0437-4","article-title":"Cannabinoids drive Th17 cell differentiation in patients with rheumatic autoimmune diseases","volume":"18","author":"Kotschenreuther","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118032_b0815","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s11481-013-9493-1","article-title":"Cannabinoids decrease the Th17 inflammatory autoimmune phenotype","volume":"8","author":"Kozela","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118032_b0820","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00109-016-1404-5","article-title":"Marijuana-derived \u0394-9-tetrahydrocannabinol suppresses Th1\/Th17 cell-mediated delayed-type hypersensitivity through microrna regulation","volume":"94","author":"Sido","year":"2016","journal-title":"J. Mol. Med."},{"issue":"7","key":"10.1016\/j.bcp.2026.118032_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114434","article-title":"CB2 stimulation of adipose resident ILC2s orchestrates immune balance and ameliorates type 2 diabetes mellitus","volume":"43","author":"Shafiei-Jahani","year":"2024","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b0830","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/can.2021.0241","article-title":"Cannabidiol: influence on B cells, peripheral blood mononuclear cells, and peripheral blood mononuclear cell\/rheumatoid arthritis synovial fibroblast cocultures","volume":"8","author":"Lowin","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b0835","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/ijms18040691","article-title":"(\u2212)-\u03b2-caryophyllene, a CB2 receptor-selective phytocannabinoid, suppresses motor paralysis and neuroinflammation in a murine model of multiple sclerosis","volume":"18","author":"Alberti","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0840","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0165-5728(94)90152-X","article-title":"Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis","volume":"55","author":"Schwarz","year":"1994","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118032_b0845","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-004-0509-9","article-title":"Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes","volume":"53","author":"Joseph","year":"2004","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0850","doi-asserted-by":"crossref","first-page":"e8688","DOI":"10.1371\/journal.pone.0008688","article-title":"Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors","volume":"5","author":"Cencioni","year":"2010","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.bcp.2026.118032_b0855","doi-asserted-by":"crossref","first-page":"10711","DOI":"10.3390\/ijms262110711","article-title":"Immunomodulatory effects of a high-CBD cannabis extract: a comparative analysis with conventional therapies for oral lichen planus and graft-versus-host disease","volume":"26","author":"Blal","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b0860","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11481-020-09912-z","article-title":"\u03949-tetrahydrocannabinol (THC) impairs CD8+ T cell-mediated activation of astrocytes","volume":"15","author":"Henriquez","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b0865","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.3390\/ijms24043125","article-title":"Effects of cannabidiol on innate immunity: experimental evidence and clinical relevance","volume":"24","author":"Martini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0870","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.intimp.2006.11.008","article-title":"Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis","volume":"7","author":"Coopman","year":"2007","journal-title":"Int. Immunopharmacol."},{"issue":"14","key":"10.1016\/j.bcp.2026.118032_b0875","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.molimm.2006.01.005","article-title":"Cannabinoid receptor CB2 modulates the CXCL12\/CXCR4-mediated chemotaxis of T lymphocytes","volume":"43","author":"Ghosh","year":"2006","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b0880","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.bjp.0707517","article-title":"Cannabinoid receptors in acute and chronic complications of atherosclerosis","volume":"153","author":"Mach","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118032_b0885","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023901","article-title":"Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion","volume":"6","author":"Nasser","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b0890","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/receptors3020007","article-title":"Molecular targets for cannabinoids in natural killer cells: do they modulate the antitumor activity?","volume":"3","author":"Olivas-Aguirre","year":"2024","journal-title":"Receptors"},{"key":"10.1016\/j.bcp.2026.118032_b0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.117896","article-title":"Immunoregulatory natural killer cells","volume":"558","author":"Roe","year":"2024","journal-title":"Clin. Chim. Acta"},{"issue":"24","key":"10.1016\/j.bcp.2026.118032_b0900","doi-asserted-by":"crossref","first-page":"17545","DOI":"10.3390\/ijms242417545","article-title":"The role of NKG2D and its ligands in autoimmune diseases: new targets for immunotherapy","volume":"24","author":"Wei","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b0905","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11481-015-9615-z","article-title":"Turning over a new leaf: cannabinoid and endocannabinoid modulation of immune function","volume":"10","author":"Cabral","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bcp.2026.118032_b0910","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pneurobio.2017.10.007","article-title":"The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: clues for other neuroinflammatory diseases","volume":"160","author":"Chiurchi\u00f9","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bcp.2026.118032_b0915","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1147520","article-title":"Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation","volume":"14","author":"P\u00e9rez-Diego","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118032_b0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114713","article-title":"Cannabidiol differentially regulates basal and LPS-induced inflammatory responses in macrophages, lung epithelial cells, and fibroblasts","volume":"382","author":"Muthumalage","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b1045","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1074\/jbc.M109.069294","article-title":"Cannabinoids \u03949-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-\u039aB and interferon-\u03b2\/STAT proinflammatory pathways in BV-2 microglial cells","volume":"285","author":"Kozela","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118032_b0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109940","article-title":"Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis","volume":"252","author":"Guadalupi","year":"2024","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.bcp.2026.118032_b0930","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118032_b0935","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118032_b0940","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.3390\/ph3082733","article-title":"Dendritic cell regulation by cannabinoid-based drugs","volume":"3","author":"Svensson","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b0945","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.4049\/jimmunol.173.4.2373","article-title":"Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-\u039aB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation","volume":"173","author":"Do","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2026.118032_b0950","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1240800","article-title":"The dual role of cannabidiol on monocyte-derived dendritic cell differentiation and maturation","volume":"14","author":"P\u00e9nzes","year":"2023","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.bcp.2026.118032_b0955","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.3390\/ijms21186795","article-title":"Cannabidiol modifies the formation of NETs in neutrophils of psoriatic patients","volume":"21","author":"W\u00f3jcik","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0960","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202300136","article-title":"Cannabidiol inhibits IgE\u2010mediated mast cell degranulation and anaphylaxis in mice","volume":"68","author":"Yang","year":"2024","journal-title":"Mol. Nutr. Food Res."},{"issue":"7","key":"10.1016\/j.bcp.2026.118032_b0965","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/all.12858","article-title":"Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen\u2010induced pulmonary inflammation in mice","volume":"71","author":"Frei","year":"2016","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0970","first-page":"C370","article-title":"Chronic edible dosing of \u03949-tetrahydrocannabinol (THC) in nonhuman primates reduces systemic platelet activity and function","volume":"322","author":"Reitsma","year":"2022","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"5","key":"10.1016\/j.bcp.2026.118032_b0975","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jaci.2021.09.037","article-title":"Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity","volume":"149","author":"Hurrell","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"16","key":"10.1016\/j.bcp.2026.118032_b0980","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.3390\/molecules28165980","article-title":"Molecular and cellular mechanisms of action of cannabidiol","volume":"28","author":"Martinez Naya","year":"2023","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b0985","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2010-01-265082","article-title":"Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization","volume":"117","author":"Jiang","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b0990","article-title":"Cannabidiol restores hematopoietic stem cell stemness in mouse through Atf2\u2013Lrp6 axis after acute irradiation","volume":"6","author":"Bai","year":"2025","journal-title":"MedComm (Beijing)"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b0995","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1186\/s12903-025-06101-3","article-title":"The activation of CB2 enhances bone remodeling in periodontitis","volume":"25","author":"Zhao","year":"2025","journal-title":"BMC Oral Health"},{"issue":"39","key":"10.1016\/j.bcp.2026.118032_b1000","doi-asserted-by":"crossref","first-page":"64853","DOI":"10.18632\/oncotarget.17614","article-title":"Activation of cannabinoid receptor type II by AM1241 protects adipose-derived mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy in myocardial infarction mice via Stat3 activation","volume":"8","author":"Han","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.bcp.2026.118032_b1005","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1194\/jlr.M061473","article-title":"Inhibition of FAAH confers increased stem cell migration via PPAR\u03b1","volume":"56","author":"Wollank","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2026.118032_b1010","doi-asserted-by":"crossref","unstructured":"I. Jialal, International Journal of Clinical and Translational Medicine. International Journal of Clinical and Translational Medicine, 2025, 1. doi:10.53941\/ijctm.2025.100001.","DOI":"10.53941\/ijctm.2025.100001"},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b1015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41375-024-02136-7","article-title":"Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche","volume":"38","author":"Chen","year":"2024","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b1020","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1152\/physrev.00002.2016","article-title":"From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology","volume":"96","author":"Ligresti","year":"2016","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13046-025-03495-4","article-title":"TRP channels and cancer modulation: a voyage beyond metabolic reprogramming, oxidative stress and the advent of nanotechnologies in targeted therapy","volume":"44","author":"Giannaccari","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41392-022-00918-y","article-title":"Cannabis suppresses antitumor immunity by inhibiting JAK\/STAT signaling in T cells through CNR2","volume":"7","author":"Xiong","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2026.118032_b1040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155076","article-title":"Activation of cannabinoid receptor 2 ameliorates DSS-induced colitis through inhibiting NLRP3 inflammasome in macrophages","volume":"11","author":"Ke","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118032_b1050","first-page":"11","article-title":"Terpenoids from cannabis do not mediate an entourage effect by acting at cannabinoid receptors","author":"Finlay","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"19","key":"10.1016\/j.bcp.2026.118032_b1055","doi-asserted-by":"crossref","first-page":"14880","DOI":"10.3390\/ijms241914880","article-title":"Effect of cannabidiol on human peripheral blood mononuclear cells and CD4+ T cells","volume":"24","author":"Furgiuele","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.118032_b1060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(02)00370-3","article-title":"\u03949-tetrahydrocannabinol regulates Th1\/Th2 cytokine balance in activated human T cells","volume":"133","author":"Yuan","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bcp.2026.118032_b1065","first-page":"1","article-title":"Immunomodulation by cannabinoids: current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application","volume":"91","author":"Kaminski","year":"2021","journal-title":"Adv. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1070","doi-asserted-by":"crossref","first-page":"e0007","DOI":"10.5041\/RMMJ.10389","article-title":"Cannabis and cannabinoids in the treatment of rheumatic diseases","volume":"11","author":"Gonen","year":"2020","journal-title":"Rambam Maimonides Med. J."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b1075","doi-asserted-by":"crossref","DOI":"10.1111\/exd.15064","article-title":"Cannabinoids for the treatment of autoimmune and inflammatory skin diseases: a systematic review","volume":"33","author":"Kuzumi","year":"2024","journal-title":"Exp. Dermatol."},{"issue":"17","key":"10.1016\/j.bcp.2026.118032_b1080","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.3390\/ijms25179356","article-title":"Cannabinoids in the inflamed synovium can be a target for the treatment of rheumatic diseases","volume":"25","author":"Roseti","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bcp.2026.118032_b1085","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3390\/biomedicines10102439","article-title":"Cannabinoid therapeutic effects in inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Vinci","year":"2022","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.bcp.2026.118032_b1090","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/ecco-jcc\/jjab069","article-title":"Oral CBD-rich cannabis induces clinical but not endoscopic response in patients with crohn\u2019s disease, a randomised controlled trial","volume":"15","author":"Naftali","year":"2021","journal-title":"J. Crohns Colitis"},{"issue":"10","key":"10.1016\/j.bcp.2026.118032_b1095","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","article-title":"Cannabis induces a clinical response in patients with crohn\u2019s disease: a prospective placebo-controlled study","volume":"11","author":"Naftali","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b1100","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s10620-017-4540-z","article-title":"Low-dose cannabidiol is safe but not effective in the treatment for crohn\u2019s disease, a randomized controlled trial","volume":"62","author":"Naftali","year":"2017","journal-title":"Dig. Dis. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b1105","first-page":"166","article-title":"The impact of cannabis on immune checkpoint inhibitor therapy: a systematic review of immunomodulatory effects of cannabis in patients with and without cancer","volume":"33","author":"Behling-Hess","year":"2025","journal-title":"Support. Care Cancer"},{"issue":"7","key":"10.1016\/j.bcp.2026.118032_b1110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11864-019-0659-9","article-title":"Should oncologists recommend cannabis?","volume":"20","author":"Abrams","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118032_b1115","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.3390\/cancers12092447","article-title":"Cannabis consumption used by cancer patients during immunotherapy correlates with poor clinical outcome","volume":"12","author":"Bar-Sela","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b1535","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/ph16020155","article-title":"Beyond pain relief: a review on cannabidiol potential in medical therapies","volume":"16","author":"Luz-Veiga","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b1540","first-page":"502","article-title":"Cannabis for the treatment of crohn\u2019s disease and ulcerative colitis: evidence from cochrane reviews","volume":"26","author":"Kafil","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b1545","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/ecco-jcc\/jjy185","article-title":"Cannabis, cannabinoids, and the endocannabinoid system\u2014is there therapeutic potential for inflammatory bowel disease?","volume":"13","author":"Ambrose","year":"2019","journal-title":"J. Crohns Colitis"},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b1550","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/ibd\/izae158","article-title":"Meta-analysis of the therapeutic impact of cannabinoids in inflammatory bowel disease","volume":"31","author":"Kang","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bcp.2026.118032_b1555","article-title":"Cannabinoids for inflammatory bowel disease: a scoping review","author":"Brodaric","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b1560","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028197","article-title":"Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study","volume":"9","author":"Hendricks","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.bcp.2026.118032_b1565","doi-asserted-by":"crossref","first-page":"361","DOI":"10.14744\/nci.2023.43669","article-title":"Cannabis therapy in rheumatological diseases: a systematic review","author":"de Carvalho","year":"2024","journal-title":"North. Clin. Istanb."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1570","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s42238-025-00342-3","article-title":"Efficacy of cannabis oil on appetite and quality of life in systemic sclerosis patients: a randomized placebo-controlled trial","volume":"7","author":"Pisprasert","year":"2025","journal-title":"J. Cannabis Res."},{"issue":"19","key":"10.1016\/j.bcp.2026.118032_b1575","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.3390\/ijms241914677","article-title":"Pharmacohistory of cannabis use\u2014a new possibility in future drug development for gastrointestinal diseases","volume":"24","author":"Thapa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2026.118032_b1120","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/dmcn.14548","article-title":"Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial","volume":"62","author":"Fairhurst","year":"2020","journal-title":"Dev. Med. Child Neurol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b1125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3390\/biomedicines10030539","article-title":"Neurological benefits, clinical challenges, and neuropathologic promise of medical marijuana: a systematic review of cannabinoid effects in multiple sclerosis and experimental models of demyelination","volume":"10","author":"Longoria","year":"2022","journal-title":"Biomedicines"},{"issue":"9395","key":"10.1016\/j.bcp.2026.118032_b1130","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","article-title":"Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS Study): multicentre randomised placebo-controlled trial","volume":"362","author":"Zajicek","year":"2003","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.bcp.2026.118032_b1135","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/epi.17000","article-title":"Long\u2010term safety and efficacy of add\u2010on cannabidiol in patients with lennox\u2013gastaut syndrome: results of a long\u2010term open\u2010label extension trial","volume":"62","author":"Patel","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2026.118032_b1140","article-title":"A comprehensive review on trends and patterns of non-communicable disease risk factors in India","author":"Sharma","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b1145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/epi.17496","article-title":"Long\u2010term efficacy and safety of cannabidiol in patients with treatment\u2010resistant epilepsies: four\u2010year results from the expanded access program","volume":"64","author":"Szaflarski","year":"2023","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b1150","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/ph17060748","article-title":"Evidence of cannabidiol effectiveness associated or not with tetrahydrocannabinol in topical administration: a scope review","volume":"17","author":"Fava","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2377-9-59","article-title":"Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review","volume":"9","author":"Lakhan","year":"2009","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118032_b1160","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3899\/jrheum.181120","article-title":"Position statement: a pragmatic approach for medical cannabis and patients with rheumatic diseases","volume":"46","author":"Fitzcharles","year":"2019","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b1165","first-page":"e93","article-title":"A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars","volume":"170","author":"Palmieri","year":"2019","journal-title":"Clin. Ter."},{"issue":"23","key":"10.1016\/j.bcp.2026.118032_b1170","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.3390\/ijms20235875","article-title":"The endocannabinoid system in pediatric inflammatory and immune diseases","volume":"20","author":"Argenziano","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b1175","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1089\/can.2020.0183","article-title":"Therapeutic prospects of cannabinoids in the immunomodulation of prevalent autoimmune diseases","volume":"6","author":"Rodr\u00edguez Mesa","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"issue":"7791","key":"10.1016\/j.bcp.2026.118032_b1185","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b1190","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/molecules29020473","article-title":"An overview of cannabidiol as a multifunctional drug: pharmacokinetics and cellular effects","volume":"29","author":"Martinez Naya","year":"2024","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b1195","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/pharmaceutics16040484","article-title":"CBD and THC in special populations: pharmacokinetics and drug\u2013drug interactions","volume":"16","author":"Qian","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1200","article-title":"Pharmacokinetics and pharmacodynamics of cannabis\u2010based medicine in a patient population included in a randomized, placebo\u2010controlled","volume":"17","author":"Hansen","year":"2024","journal-title":"Clinical Trial. Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1205","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70119","article-title":"physiologically based pharmacokinetic modeling of cannabidiol, delta\u20109\u2010tetrahydrocannabinol, and their metabolites in healthy adults after administration by multiple routes","volume":"18","author":"Qian","year":"2025","journal-title":"Clin. Transl. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b1210","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1089\/can.2023.0025","article-title":"Pharmacokinetics of cannabidiol: a systematic review and meta-regression analysis","volume":"9","author":"Moazen-Zadeh","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.bcp.2026.118032_b1215","article-title":"Drug interactions of tetrahydrocannabinol and cannabidiol in cannabinoid drugs","author":"Herdegen","year":"2023","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.bcp.2026.118032_b1220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2023.07.029","article-title":"Cannabidiol\u2019s impact on drug-metabolization","volume":"118","author":"St\u00f6llberger","year":"2023","journal-title":"Eur. J. Intern. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b1225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.therap.2023.05.003","article-title":"Cannabidiol and pharmacokinetics drug-drug interactions: pharmacological toolbox","volume":"79","author":"Lacroix","year":"2024","journal-title":"Therapies"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/kei183","article-title":"Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (sativex) in the treatment of pain caused by rheumatoid arthritis","volume":"45","author":"Blake","year":"2006","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.bcp.2026.118032_b1235","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1179\/016164109X12590518685660","article-title":"A double-blind, randomized, placebo-controlled, parallel-group study of sativex, in subjects with symptoms of spasticity due to multiple sclerosis","volume":"32","author":"Collin","year":"2010","journal-title":"Neurol. Res."},{"issue":"14","key":"10.1016\/j.bcp.2026.118032_b1240","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005254","article-title":"Randomized, dose-ranging safety trial of cannabidiol in dravet syndrome","volume":"90","author":"Devinsky","year":"2018","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.bcp.2026.118032_b1245","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/s41386-020-0667-2","article-title":"Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials","volume":"45","author":"Chesney","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7812\/TPP\/19.200","article-title":"Mechanisms of action and pharmacokinetics of cannabis","volume":"25","author":"Chayasirisobhon","year":"2021","journal-title":"Perm. J."},{"issue":"A","key":"10.1016\/j.bcp.2026.118032_b1255","doi-asserted-by":"crossref","DOI":"10.1155\/2005\/242516","article-title":"Pharmacokinetics of cannabinoids","volume":"10","author":"McGilveray","year":"2005","journal-title":"Pain Res. Manag."},{"issue":"11","key":"10.1016\/j.bcp.2026.118032_b1260","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b1265","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1124\/dmd.121.000442","article-title":"Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions","volume":"49","author":"Nasrin","year":"2021","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b1270","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/03602532.2024.2346767","article-title":"Effects of cannabidiol and \u0394 9 -tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review","volume":"56","author":"Smith","year":"2024","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bcp.2026.118032_b1275","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.08.014","article-title":"Cannabis use during pregnancy: pharmacokinetics and effects on child development","volume":"182","author":"Grant","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1280","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40748-025-00216-9","article-title":"Meta-analysis of maternal and neonatal outcomes of cannabis use in pregnancy current to march 2024","volume":"11","author":"Sainz","year":"2025","journal-title":"Matern. Health Neonatol. Perinatol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1285","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1756285615612659","article-title":"Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis","volume":"9","author":"Zettl","year":"2016","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"S1","key":"10.1016\/j.bcp.2026.118032_b1290","first-page":"S51","article-title":"Pharmacokinetics of oral minor cannabinoids in blood and brain","volume":"8","author":"Moore","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"issue":"10","key":"10.1016\/j.bcp.2026.118032_b1295","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s40266-021-00882-2","article-title":"Safety and tolerability of natural and synthetic cannabinoids in older adults: a systematic review and meta-analysis of open-label trials and observational studies","volume":"38","author":"Pisani","year":"2021","journal-title":"Drugs Aging"},{"issue":"S1","key":"10.1016\/j.bcp.2026.118032_b1300","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1089\/can.2023.0038","article-title":"A two-phase, dose-ranging, placebo-controlled study of the safety and preliminary test of acute effects of Oral \u0394 8 -tetrahydrocannabivarin in healthy participants","volume":"8","author":"Peters","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"issue":"11","key":"10.1016\/j.bcp.2026.118032_b1580","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118032_b1585","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bcp.2026.118032_b1590","first-page":"9","article-title":"A systematic review on the pharmacokinetics of cannabidiol in humans","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118032_b1595","doi-asserted-by":"crossref","DOI":"10.46756\/001c.147463","article-title":"Safety assessment on cannabidiol (CBD) used as a novel food for use in food supplements (RP354)","author":"Food Standards Agency; Food Standards Scotland","year":"2025","journal-title":"FSA Res. Evidence"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1600","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1038\/s41598-025-87621-4","article-title":"A high-fat meal significantly impacts the bioavailability and biphasic absorption of cannabidiol (CBD) from a CBD-rich extract in men and women","volume":"15","author":"Saals","year":"2025","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b1605","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.xphs.2021.08.012","article-title":"Improved bioavailability with dry powder cannabidiol inhalation: a phase 1 clinical study","volume":"110","author":"Devinsky","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.118032_b1610","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jat\/bkab124","article-title":"Pharmacokinetic profile of \u03949-tetrahydrocannabinol, cannabidiol and metabolites in blood following vaporization and oral ingestion of cannabidiol products","volume":"46","author":"Bergeria","year":"2022","journal-title":"J. Anal. Toxicol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b1615","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00228-021-03232-8","article-title":"pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and \u03949-tetrahydrocannabinol: a pilot study","volume":"78","author":"Peters","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b1620","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3390\/ph17121603","article-title":"Pharmacokinetics of oral cannabinoid \u03948-tetrahydrocannabivarin and its main metabolites in healthy participants","volume":"17","author":"Sempio","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"58","key":"10.1016\/j.bcp.2026.118032_b1305","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jncimonographs\/lgab009","article-title":"Challenges for clinical cannabis and cannabinoid research in the United States","volume":"2021","author":"Cooper","year":"2021","journal-title":"JNCI Monographs"},{"key":"10.1016\/j.bcp.2026.118032_b1310","doi-asserted-by":"crossref","unstructured":"The Health Effects of Cannabis and Cannabinoids; National Academies Press: Washington, D.C., 2017. doi:10.17226\/24625.","DOI":"10.17226\/24625"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1315","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s42238-020-00026-0","article-title":"A pharmacological characterization of cannabis sativa chemovar extracts","volume":"2","author":"Devsi","year":"2020","journal-title":"J. Cannabis Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1320","doi-asserted-by":"crossref","first-page":"21801","DOI":"10.1038\/s41598-021-01378-0","article-title":"The impact of extraction protocol on the chemical profile of cannabis extracts from a single cultivar","volume":"11","author":"Bowen","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b1325","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/pharmaceutics17020236","article-title":"Pharmacokinetics of Non-psychotropic phytocannabinoids","volume":"17","author":"Lacerda","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2026.118032_b1330","first-page":"12","article-title":"Cannabinoids: biosynthesis, molecular pharmacology and potential therapeutic uses","author":"Walsh","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5\u20136","key":"10.1016\/j.bcp.2026.118032_b1335","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lfs.2011.05.018","article-title":"Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes","volume":"89","author":"Jiang","year":"2011","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1340","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s42238-025-00274-y","article-title":"Beyond the hype: a comprehensive exploration of CBD\u2019s biological impacts and mechanisms of action","volume":"7","author":"Swenson","year":"2025","journal-title":"J. Cannabis Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118032_b1345","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2026.118032_b1350","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4103\/neurol-india.NI_579_20","article-title":"Neutrophil-to-lymphocyte Ratio, ESR, and CRP have no roles as markers for disease severity and prognosis in patients with RRMS","volume":"72","author":"Nikseresht","year":"2024","journal-title":"Neurol. India"},{"issue":"2","key":"10.1016\/j.bcp.2026.118032_b1355","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcma.2015.08.010","article-title":"Is there an association between the expanded disability status scale and inflammatory markers in multiple sclerosis?","volume":"79","author":"Guzel","year":"2016","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.bcp.2026.118032_b1360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2024.110990","article-title":"Association of serum levels of inflammation and oxidative stress markers with cognitive outcomes in multiple sclerosis; a systematic review","volume":"132","author":"Daneshvar","year":"2025","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.bcp.2026.118032_b1365","doi-asserted-by":"crossref","unstructured":"The Health Effects of Cannabis and Cannabinoids; National Academies Press: Washington, D.C., 2017. doi:10.17226\/24625.","DOI":"10.17226\/24625"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1370","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","article-title":"Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies","volume":"162","author":"Finn","year":"2021","journal-title":"Pain"},{"issue":"12","key":"10.1016\/j.bcp.2026.118032_b1375","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3390\/biom15121668","article-title":"Pharmacological and pharmacokinetic profile of cannabidiol in human epilepsy: a review of metabolism, therapeutic drug monitoring, and interactions with antiseizure medications","volume":"15","author":"Na","year":"2025","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bcp.2026.118032_b1380","article-title":"Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis","volume":"2025","author":"Ridley","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"issue":"13","key":"10.1016\/j.bcp.2026.118032_b1385","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.cgh.2015.06.034","article-title":"Effects of concomitant immunomodulator therapy on efficacy and safety of anti\u2013tumor necrosis factor therapy for crohn\u2019s disease: a meta-analysis of placebo-controlled trials","volume":"13","author":"Jones","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:33:33Z","timestamp":1792888413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226003655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":324,"alternative-id":["S0006295226003655"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118032","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoids in autoimmune diseases: mechanistic insights and translational challenges","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118032"}}